Neuralink
Signal active
Organization
Contact Information
Overview
Neuralink develops a brain-machine interface that provides solutions for those with paralysis. Neuralink engages in the development of high-bandwidth brain-machine interfaces. It is driven to build devices that will help people with paralysis and invent new technologies that will expand their abilities and community.
About
Industries
Biotechnology, Medical, Robotics, Neuroscience
Founded
2016
Employees
251-500
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Neuralink headquartered in United States, North America, operates in the Biotechnology, Medical, Robotics, Neuroscience sector. The company focuses on Biotechnology and has secured $87.8B in funding across 128 round(s). With a team of 251-500 employees, Neuralink is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Neuralink, raised $107.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
1
Lead Investors
0
Total Funding Amount
$686.2M
Details
5
Neuralink has raised a total of $686.2M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Late Stage Venture | 205.0M | ||
| 2023 | Late Stage Venture | 323.2M | ||
| 1901 | Late Stage Venture | |||
| 2017 | Early Stage Venture | 107.0M |
Investors
Neuralink is funded by 26 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Neuralink | - | FUNDING ROUND - Neuralink | undefined |
| Bull & Bear | - | FUNDING ROUND - Bull & Bear | undefined |
| Neuralink | - | FUNDING ROUND - Neuralink | 107.0M |
| UpHonest Capital | - | FUNDING ROUND - UpHonest Capital | 107.0M |
Recent Activity
There is no recent news or activity for this profile.